YILMAZ, S. Et Al. 2018. Could serum S100B be a predictor of neuronal damage and clinical poor outcomes associated with the use of synthetic cannabinoids? S100B to predict neuronal damage of SC in the ED. AMERICAN JOURNAL OF EMERGENCY MEDICINE , vol.36, no.3 , 435-441.

YILMAZ, S., Karakayali, O., Kale, E., & Akdogan, A., (2018). Could serum S100B be a predictor of neuronal damage and clinical poor outcomes associated with the use of synthetic cannabinoids? S100B to predict neuronal damage of SC in the ED. AMERICAN JOURNAL OF EMERGENCY MEDICINE , vol.36, no.3, 435-441.

YILMAZ, SERKAN Et Al. "Could serum S100B be a predictor of neuronal damage and clinical poor outcomes associated with the use of synthetic cannabinoids? S100B to predict neuronal damage of SC in the ED," AMERICAN JOURNAL OF EMERGENCY MEDICINE , vol.36, no.3, 435-441, 2018

YILMAZ, SERKAN Et Al. "Could serum S100B be a predictor of neuronal damage and clinical poor outcomes associated with the use of synthetic cannabinoids? S100B to predict neuronal damage of SC in the ED." AMERICAN JOURNAL OF EMERGENCY MEDICINE , vol.36, no.3, pp.435-441, 2018

YILMAZ, S. Et Al. (2018) . "Could serum S100B be a predictor of neuronal damage and clinical poor outcomes associated with the use of synthetic cannabinoids? S100B to predict neuronal damage of SC in the ED." AMERICAN JOURNAL OF EMERGENCY MEDICINE , vol.36, no.3, pp.435-441.

@article{article, author={SERKAN YILMAZ Et Al. }, title={Could serum S100B be a predictor of neuronal damage and clinical poor outcomes associated with the use of synthetic cannabinoids? S100B to predict neuronal damage of SC in the ED}, journal={AMERICAN JOURNAL OF EMERGENCY MEDICINE}, year=2018, pages={435-441} }